98 related articles for article (PubMed ID: 20655904)
21. Inhibitory effect of a novel orally active GP IIb/IIIa inhibitor, SC-54684A on intimal thickening in the guinea pig femoral artery.
Umemura K; Nishiyama H; Kikuchi S; Kondo K; Nakashima M
Thromb Haemost; 1996 Nov; 76(5):799-806. PubMed ID: 8950793
[TBL] [Abstract][Full Text] [Related]
22. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
23. Comparison of in vitro platelet aggregation and its inhibition by three antithrombotic drugs between human and guinea pig.
Huang ZS; Lee TK
Proc Natl Sci Counc Repub China B; 1991 Feb; 15(1):8-14. PubMed ID: 1946813
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
25. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
26. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats.
Andrade-Gordon P; Derian CK; Maryanoff BE; Zhang HC; Addo MF; Cheung Wm ; Damiano BP; D'Andrea MR; Darrow AL; de Garavilla L; Eckardt AJ; Giardino EC; Haertlein BJ; McComsey DF
J Pharmacol Exp Ther; 2001 Jul; 298(1):34-42. PubMed ID: 11408522
[TBL] [Abstract][Full Text] [Related]
27. Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesion.
Basic-Micic M; Breddin HK
Semin Thromb Hemost; 1993; 19 Suppl 1():22-8. PubMed ID: 8395725
[TBL] [Abstract][Full Text] [Related]
28. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation.
Lovely RS; Rein CM; White TC; Jouihan SA; Boshkov LK; Bakke AC; McCarty OJ; Farrell DH
Thromb Haemost; 2008 Nov; 100(5):837-46. PubMed ID: 18989528
[TBL] [Abstract][Full Text] [Related]
29. [Effects of tetrandrine on platelet aggregation, platelet adhesion and coagulation].
Wu S; Zhao Z; Qi H
Zhongguo Zhong Yao Za Zhi; 1990 Apr; 15(4):233-5, 255-6. PubMed ID: 2206376
[TBL] [Abstract][Full Text] [Related]
30. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
[TBL] [Abstract][Full Text] [Related]
31. Plasmin inhibition of thrombin-induced platelet aggregation.
Miller JL; Katz AJ; Feinstein MB
Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
[TBL] [Abstract][Full Text] [Related]
32. Effects of propylene glycol mannate sulfate on thrombosis in abdominal aorta in rabbits.
Chen XM; Pan JQ; Zhang ZN
Zhongguo Yao Li Xue Bao; 1995 May; 16(3):226-30. PubMed ID: 7660816
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.
Kasuda S; Sakurai Y; Shima M; Morimura Y; Kudo R; Takeda T; Ishitani A; Yoshioka A; Hatake K
Alcohol Clin Exp Res; 2006 Sep; 30(9):1608-14. PubMed ID: 16930224
[TBL] [Abstract][Full Text] [Related]
34. Stilbenoids from Gnetum macrostachyum attenuate human platelet aggregation and adhesion.
Kloypan C; Jeenapongsa R; Sri-in P; Chanta S; Dokpuang D; Tip-pyang S; Surapinit N
Phytother Res; 2012 Oct; 26(10):1564-8. PubMed ID: 22511550
[TBL] [Abstract][Full Text] [Related]
35. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
36. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
37. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
38. Protease-activated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism.
Di Serio C; Pellerito S; Duarte M; Massi D; Naldini A; Cirino G; Prudovsky I; Santucci M; Geppetti P; Marchionni N; Masotti G; Tarantini F
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):63-9. PubMed ID: 17577318
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of platelet adhesion and aggregation by E4021, a type V phosphodiesterase inhibitor, in guinea pigs.
Chiu PJ; Vemulapalli S; Chintala M; Kurowski S; Tetzloff GG; Brown AD; Sybertz EJ
Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):463-9. PubMed ID: 9109362
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists.
Ahn HS; Arik L; Boykow G; Burnett DA; Caplen MA; Czarniecki M; Domalski MS; Foster C; Manna M; Stamford AW; Wu Y
Bioorg Med Chem Lett; 1999 Jul; 9(14):2073-8. PubMed ID: 10450984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
